"This global collaboration provides our customers with a confident and straightforward solution to move from NimbleGen to Agilent microarrays," said Dan Zabrowski, Head of Roche Applied Science. "With Agilent as a leading global supplier of microarray technology, we are convinced researchers will be provided with the highest compatibility to NimbleGen products and services, and believe that they will continue to receive the exceptional service and support they have come to expect."
"We are working closely with Roche to help customers make the transition to Agilent microarray products," said Robert Schueren, vice president and general manager of Agilent's Genomics Systems Division. "Our field service personnel are working directly with individual researchers to help convert their NimbleGen designs, and they will continue to provide enhanced service and support throughout the transition period and beyond. Additionally, Agilent is also enabling customers to read their arrays on NimbleGen scanners, eliminating the need to invest in capital equipment."
For more information about the transition, visit www.agilent.com/.... For questions relating to service and support of NimbleGen microarray products, call 1-800-227-9770, or email: genomics@agilent.com.
About Agilent Technologies
Agilent Technologies Inc. (NYSE: A) is the world's premier measurement company and a technology leader in chemical analysis, life sciences, diagnostics, electronics and communications. The company's 20,000 employees serve customers in more than 100 countries. Agilent had net revenues of $6.6 billion in fiscal 2011. Information about Agilent is available at www.agilent.com.
For life science research only. Not for use in diagnostic procedures
NIMBLEGEN is a trademark of Roche.
All other product names and trademarks are the property of their respective owners.